Lee L Jennings

A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis

D. Silberg, Patrick Martin, C. Bliss, 2018, BMC Pharmacology and Toxicology.

Orally Bioavailable β3-Adrenergic Receptor Agonists as Potential Therapeutic Agents for Obesityand Type-II Diabetes

Baihua Hu, Lee L Jennings, 2003 .

A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis

D. Silberg, Patrick Martin, C. Bliss, 2018, BMC Pharmacology and Toxicology.

Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes.

Baihua Hu, Lee L Jennings, 2003, Progress in medicinal chemistry.

Absorption, Distribution, Metabolism, and Excretion of [14C]-Volixibat in Healthy Men: Phase 1 Open-Label Study

D. Silberg, Patrick Martin, C. Bliss, 2017, European Journal of Drug Metabolism and Pharmacokinetics.